Contact Us
Drug Search Results
More Filters [+]

Topsalysin

Alternative Names: topsalysin, PRX-302, PRX302, PRX 302
Latest Update: 2024-05-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Fusion Protein

Route of Administration: Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Sophiris Bio
Company Location: LA JOLLA CA 92037
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Topsalysin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Lower Urinary Tract Symptoms|Prostatic Hyperplasia

Phase 2: Prostatic Hyperplasia|Prostate Cancer|Lower Urinary Tract Symptoms

Phase 1: Prostate Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
Intraprostatic PRX302 injection to treat localised prostate cancer

P2

Terminated

Prostate Cancer

2018-11-30

PRX302-2-08

P2

Completed

Prostate Cancer

2018-11-28

25%
PRX302-2-07

P2

Completed

Prostate Cancer

2016-06-01

Intraprostatic PRX302 injection to treat localised prostate cancer

P2

Completed

Prostate Cancer

2016-05-11

Recent News Events

Date

Type

Title

05/01/2024

PubMed

 Two-year follow-up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study.

06/01/2022

PubMed

 [Minimally Invasive Therapy: What Is The Status In 2021 - What's Coming, What's Going?].

03/01/2021

PubMed

 A state-of-art review on the preservation of sexual function among various minimally invasive surgical treatments for benign prostatic hyperplasia: Impact on erectile and ejaculatory domains.

07/24/2020

News Article

 Prostate Cancer Market Trends & Epidemiology Forecast to 2030 - United States, Germany, France, Italy, Spain, United Kingdom and Japan

07/23/2020

News Article

 Prostate Cancer Market Study (2017-2030) in 7MM - Epidemiology Insights, Marketed & Emerging Drugs, Pipeline Activities, Access & Reimbursement Scenario, Competitive Intelligence

07/22/2020

News Article

 Prostate Cancer Market Insights and Epidemiology 2017-2030 - ResearchAndMarkets.com

06/09/2020

News Article

 Prostate Cancer Market Size Anticipated to Increase with a CAGR of 8.1% in the 7MM for the Study Period 2017-30

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions